• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A leading pure play vaccine company.

ABR_Website_Image.jpg

— June 08, 2017

Valneva Announces the Availability of Documentation for its Meetings of Shareholders

Read more

— Stock information

@valnevase




















-
— April 18, 2017
Valneva Announces Signing of a New EB66® Commercial License with Bavarian Nordic

Read more
— Financial Calendar

June 29, 2017
Annual General Meeting 2017

August 31, 2017
HY 2017 Financial Statements

November 9, 2017
Q3 2017 Interim Results

See all dates


KOL event in N.Y. on Lyme disease (webcast)



JAPANESE
ENCEPHALITIS
AND
CHOLERA



learn more
play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

– Upcoming conferences and fairs


Jefferies 2017 Global Healthcare Conference
New York, US
June 6-9, 2017

Kepler Biotech Days
Paris, France
June 8-9, 2017

2017 BIO International Convention
San Diego, US
June 19-22, 2017

16th Euro Global Summit and Expo on Vaccines & Vaccination; Accelerating Next Generation Vaccines for Global Health
Paris, France
June 19-21, 2017
Please update your browser...